Debbie's Place

A Patient's Point of View




Delta9-tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism.                                                                            (abst -1999)


Suppression of Nerve Growth Factor Trk Receptors and Prolactin Receptors by Endocannabinoids Leads to Inhibition of Human Breast and Prostate Cancer Cell Proliferation (full – 2000)  776


Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production. (abst – 2003)


Expression of functionally active cannabinoid receptor CB1 in the human prostate gland (abst – 2003)                            


2-Arachidonoylglycerol A Novel Inhibitor of Androgen-Independent Prostate Cancer Cell Invasion       (full – 2004)  f2b094


A new class of inhibitors of 2-arachidonoylglycerol hydrolysis and invasion of prostate cancer cells.        (full – 2005)


Cannabinoid Receptor as a Novel Target for the Treatment of Prostate Cancer (full – 2005)                                 


Cannabinoid Receptor Agonist-induced Apoptosis of Human Prostate Cancer Cells LNCaP Proceeds through Sustained Activation of ERK1/2 Leading to G1 Cell Cycle Arrest (full – 2006)              


Diverse roles of 2-arachidonoylglycerol in invasion of prostate carcinoma cells: Location, hydrolysis and 12-lipoxygenase metabolism                                             (full – 2007)


US Patent Application 20070041994 – Compositions and methods for treating prostate disorders            ( full – 2007)          


Cannabinoid receptors agonist WIN-55,212-2 inhibits angiogenesis, metastasis and tumor growth of androgen-sensitive prostate cancer cell CWR22R{nu}1 xenograft in athymic nude mice       (abst – 2007) ow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=720&resourcety  pe=HWCIT


Cannabinoids for Cancer Treatment: Progress and Promise               (full – 2008)


Endocannabinoids in endocrine and related tumours              (full – 2008)



Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)- Methanandamide and JWH-015: Involvement of CB2                                                                   (full – 2009)


The cannabinoid R+ methanandamide induces IL-6 secretion by prostate cancer PC3 cells.          (abst – 2009)            


Active Chemicals in Cannabis Inhibits Prostate Cancer Cell Growth                 (news – 2009)


Cannabis is linked to a ‘cancer cure’.                (news – 2009)


Cannabis chemicals may help fight prostate cancer                  (news – 2009)


Chemicals in cannabis found to stop prostate cancer               (news – 2009)  cannabis-found-to-stop-prostate-cancer


Active cannabis chemicals halt prostate cancer cell growth                (news – 2009)  growth.aspx


Cannabis may apparently stop prostate cancer growth                (news – 2009)


Medical Marijuana and Cancer, Prostate                 (news – 2009)


Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines. (full – 2010)                             


The endocannabinoid system and cancer: therapeutic implication                 (full – 2011)


Phytocannabinoids for use in the treatment of cancer   – Patent GB2478595  (A) ― 2011-09-14 (full – 2011)



The endocannabinoid system in prostate cancer.             (abst – 2011)


Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines.                                                      (abst – 2011)




Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent.      (abst – 2011)            


The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation.       (abst – 2011)                 


The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications. (full – 2012)


Cannabinoid Receptor Type 1 (CB1) Activation Inhibits Small GTPase RhoA Activity and Regulates Motility of Prostate Carcinoma Cells                                                          (full – 2012)


Towards the use of non-psychoactive cannabinoids for prostate cancer.             (full – 2012)


Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series                                                   (full – 2012)


Tumour epithelial expression levels of endocannabinoid markers modulates the value of endoglin-positive vascular density as a prognostic marker in prostate cancer.

(abst – 2012)      


Receptor-dependent and Receptor-independent Endocannabinoid Signaling: A Therapeutic Target for Regulation of Cancer Growth.                                                                           (abst – 2012)


Is Marijuana the Cancer Cure We’ve Waited For?                   (news – 2012)


Tommy Chong Fighting Prostate Cancer With Cannabis Oil                 (news – 2012)  Oil


Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro- apoptotic effects and underlying mechanisms.                                               (full – 2013)


Towards the use of non-psychoactive cannabinoids for prostate cancer               (full – 2013)

Share a link for

1 Comment

  1. Hello, this weekend is fastidious in favor of me, as this point in time i am reading this impressive informative paragraph here at my residence.

Leave a Reply

Your email address will not be published.


© 2019 Debbie's Place

Powered by